Average Co-Inventor Count = 2.30
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. E.i. Dupont De Nemours and Company (24 from 16,338 patents)
2. National Institutes of Health, a Component of the US Dept. of Health & Human Services (20 from 3,435 patents)
3. Other (1 from 832,680 patents)
4. Mars, Incorporated (1 from 1,194 patents)
5. Immunocore Limited (1 from 45 patents)
46 patents:
1. 12441778 - T cell receptors recognizing HLA-A1-restricted MAGE-A3
2. 11879017 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
3. 11306131 - T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage
4. 11124580 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
5. 10864252 - Anti-SSX-2 T cell receptors and related materials and methods of use
6. 10570214 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
7. 10407485 - Murine anti-NY-ESO-1 T cell receptors
8. 10143724 - Anti-SSX-2 T cell receptors and related materials and methods of use
9. 10087230 - Murine anti-NY-ESO-1 T cell receptors
10. 9688739 - T cell receptors and related materials and methods of use
11. 9624306 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
12. 9487573 - Murine anti-NY-ESO-1 T cell receptors
13. 9345748 - Anti-SSX-2 T cell receptors and related materials and methods of use
14. 9266960 - Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
15. 9128080 - Modified T cell receptors and related materials and methods